Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.400
0.00 (0.00%)
Aug 7, 2026, 9:41 AM EDT - Market open

Allarity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
22179318778
Market Cap Growth
46.25%103.26%163.38%-98.26%138.20%-
Enterprise Value
23.964.08-9.646.12192.5360.88
Last Close Price
1.401.081.17330.66246792.008714580.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
64.5754.27----
PB Ratio
3.201.770.72-0.72-1653.294.32
P/TBV Ratio
3.151.580.16---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
69.4512.75----
EV/EBITDA Ratio
--0.35---
EV/EBIT Ratio
--0.35---
EV/FCF Ratio
--0.55---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.900000.960.05
Net Debt / Equity Ratio
0.24-1.35-1.54-0.25-15.10-1.04
Net Debt / EBITDA Ratio
-0.141.050.67-0.07-0.050.71
Net Debt / FCF Ratio
-0.100.901.03-0.09-0.101.26
Asset Turnover
0.010.020000
Quick Ratio
0.751.842.000.070.251.00
Current Ratio
1.232.132.060.140.441.03
Return on Equity (ROE)
-134.33%-103.80%-541.17%-2084.24%-137.78%-121.53%
Return on Assets (ROA)
-46.10%-61.63%-160.28%-128.82%-98.11%-63.64%
Return on Invested Capital (ROIC)
-476.46%---1032.71%-1016.18%-198.97%
Return on Capital Employed (ROCE)
-146.37%-116.50%-573.13%-3368.53%-213.82%-93.53%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-254.81%-794.78%----
Total Shareholder Return
-254.81%-794.78%----
SEC Filings: 10-K · 10-Q